Coherus Oncology (CHRS) Change in Inventory (2018 - 2026)
Coherus Oncology (CHRS) posted Change in Inventory of $11.3 million for Q1 2026, up 915.44% sequentially from $1.1 million in Q4 2025, and down 49.15% YoY from $22.2 million in Q1 2025.
Coherus Oncology (CHRS) Change in Inventory (2018 - 2026) Analysis & Trends
Coherus Oncology has reported Change in Inventory for 9 years, with the latest figure at $11.3 million in Q1 2026.
- Quarterly Change in Inventory fell 49.15% year-over-year to $11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 million (down 85.55% YoY) and the FY2025 annual result came in at $17.1 million, down 46.46% from the prior year.
- Change in Inventory climbed to $11.3 million in Q1 2026 per CHRS's latest filing, from $1.1 million in the prior quarter.
- Over five years, Change in Inventory peaked at $23.4 million in Q3 2022 and troughed at -$3.8 million in Q2 2025.
- A 5-year average of $9.1 million and a median of $9.8 million in 2022 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2022 and 2025: Change in Inventory surged 443.63% in 2022, then tumbled 153.08% in 2025.
- Over 5 years, Change in Inventory stood at $9.8 million in 2022, then rose by 20.44% to $11.8 million in 2023, then plunged by 45.28% to $6.5 million in 2024, then tumbled by 82.74% to $1.1 million in 2025, then soared by 915.44% to $11.3 million in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered $11.3 million, $1.1 million, and -$2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Coherus Oncology | 221.39 Mn | 116.08 Mn | 10.07 Mn | -437,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -437,000.00 |
| Jun 30, 2026 | -437,000.00 |
| Mar 31, 2026 | 11.31 Mn |
| Mar 31, 2026 | 11.31 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | -2.48 Mn |
| Sep 30, 2025 | -2.48 Mn |
| Jun 30, 2025 | -3.77 Mn |
| Jun 30, 2025 | -3.77 Mn |
| Mar 31, 2025 | 22.24 Mn |
| Mar 31, 2025 | 22.24 Mn |
| Dec 31, 2024 | 6.45 Mn |
| Dec 31, 2024 | 6.45 Mn |
| Sep 30, 2024 | 6.94 Mn |
| Sep 30, 2024 | 6.94 Mn |
| Jun 30, 2024 | 7.10 Mn |
| Jun 30, 2024 | 7.10 Mn |
| Mar 31, 2024 | 11.46 Mn |
| Mar 31, 2024 | 11.46 Mn |